logo
Poisonous plant 'threatens' riding school's horses

Poisonous plant 'threatens' riding school's horses

Yahoo4 days ago
An invasive plant species poisonous to horses is threatening the future of a charity riding school, its director has said.
Margaret Haes Riding Centre in Holcombe, Greater Manchester, said it had been left in a "desperate situation" because the horses' grazing area had become overrun with ragwort.
Director Debra Batchelor has asked for volunteers to help clear the plant, which can cause fatal liver disease and neurological issues in horses, before its flowers bloom and disperse yet more seeds.
"This year we are overwhelmed," she said. "There's so much to dig up. If we don't get to it before it flowers we will be in trouble."
Ragwort, with its yellow flowers attracting pollinating insects such as bees, butterflies and moths, is a valuable plant for wildlife and pollinating insects.
However, it poses a significant risk to horses.
Ms Batchelor said her riding school, which is volunteer-led with only a small staff of paid professional riding instructors, can normally remove the plant themselves.
She thinks it may be more prevalent this year since many people are allowing it to grow.
Ms Batchelor said ragwort was a threat to the horses' quality of life as well as their health.
"The horses [currently] live an outdoor life in a herd," she explained.
"It's a large field so if we can't clear it we're going to have to look at keeping them in the stables which isn't fair.
"They give so much and do so much for the people who come here - they deserve so much more."
Margaret Haes Riding Centre offers discounted riding lessons for children and adults with disabilities.
A group of volunteers from Red Rose Recovery, an organisation with bases across Lancashire that supports people affected by substance misuse, poor mental health and offending behaviours, last week worked on clearing the grazing field.
A spokesperson said: "As part of our community action we look for ways that our beneficiaries can give back to and help support their community.
"The group consisted of people with different abilities and levels of physical health.
"Those that were able to participate in the manual work did and enjoyed doing so.
"Even the ones that weren't able to still enjoyed the connection and being outside with the horses in the fresh air."
Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Margaret Haes Riding School
Red Rose Recovery
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Church of England considers holy communion options for gluten-intolerant
Church of England considers holy communion options for gluten-intolerant

Yahoo

timean hour ago

  • Yahoo

Church of England considers holy communion options for gluten-intolerant

The Church of England is looking into the options for people who cannot eat gluten or drink alcohol to receive holy communion. Earlier this year the Church issued a statement to clarify it was not banning gluten-free bread or non-alcoholic communion wine, following a widely-reported question asked ahead of its February General Synod. That question noted that under Church law the use of wheat alternatives for communion bread such as rice or potato flour 'are prohibited' and that communion wine would always have at least a residual alcohol content. Asker Reverend Canon Alice Kemp described it as an 'injustice' that some people could therefore not partake in communion. Holy communion is one of the central sacraments of the Christian faith, with the bread and wine given to the congregation symbolising the body and blood of Christ. The Church confirmed gluten-free bread or non-alcoholic wine is routinely offered at churches across the country, noting that many professional ecclesiastical suppliers have long provided wine or bread 'which may contain tiny traces of alcohol or gluten which can legitimately be considered non-alcoholic or gluten-free'. Ahead of this month's Synod, another member asked what progress had been made on ensuring people who are unable to consume gluten or alcohol 'in even trace amounts' can receive holy communion. Bishop of Lichfield, the Right Reverend Dr Michael Ipgrave, said those who 'cannot physically receive the sacrament (including those who may have an allergy or intolerance to one or both elements) are to be assured that they are partakers by faith of the body and blood of Christ and of the benefits he conveys to us by them'. He added that the accessible liturgy working group is looking at providing guidance for best practice in the administration of holy communion and considering the specific case of someone who cannot consume even trace amounts of gluten or alcohol 'and the theological, liturgical, and legal basis for the teaching of the Church of England on this matter'. Synod – known as the Church's parliament – will run from Friday to Tuesday. It will, in a rare occurrence, hear from a senior military figure on Friday afternoon. Brigadier Jaish Mahan, a Christian who served in Kosovo, Sierra Leone, Iraq and Afghanistan, will address Synod members on the current global climate and the challenges for the UK, as well as speaking of his own experience in the military. It comes after the Church confirmed it is preparing for how it might respond should 'serious conflict' break out, including looking back to the leadership shown by senior religious figures during the Second World War. Legislative changes are due to be brought before Synod, which would allow Armed Forces chaplains, when operating in their roles, to minister under an Archbishops' licence without also having to hold diocesan PTO (permission to officiate). The current rules add a serious administrative burden and make it more difficult for chaplains to deploy within the UK at the pace required by their roles, a Synod paper states.

Do you need HRT? Here's what the menopause doctors say
Do you need HRT? Here's what the menopause doctors say

Yahoo

timean hour ago

  • Yahoo

Do you need HRT? Here's what the menopause doctors say

Asha turned 60 last year, but says she has the hormones of a 26-year-old. When she went through the menopause at 47, she felt 'dead from the neck down. My libido disappeared and I was plagued with hot flushes, night sweats and weight gain. Then a private menopause doctor prescribed me compounded bioidentical hormones to fit my exact profile and it changed my life…' Asha's experience is intriguing. As little as a decade ago, HRT – hormone replacement therapy – was pretty much out of the question. Studies in 2002 had linked it to breast cancer, and few women dared risk it. But it's had something of a renaissance in the last few years since dozens of studies have provided evidence that HRT may be safer than previously believed. Around 15 per cent of women aged 45 to 64 in England are currently prescribed HRT. But what of the women for whom HRT would be considered low-risk but don't take it – with so many long-term health benefits, are they missing out? Types of HRT What are the risks of HRT? What are the effects of stopping HRT? Benefits of HRT Side effects Finding a hormone replacement doctor Hormone replacement therapy is medication, taken in the form of tablets, gels, patches, sprays, creams and pessaries, that contains oestrogen that our bodies stop making during menopause. HRT's purpose is to tackle menopausal symptoms such as hot flushes, anxiety, low mood and vaginal discomfort. Your doctor will typically prescribe oestrogen along with progesterone or progestin (progesterone-like medication) to prevent growth of the lining of the uterus which increases the risk of endometrial cancer – unless you have had your uterus removed, in which case you'd take oestrogen on its own. A specialist doctor may also prescribe testosterone which can be effective at improving sexual wellbeing for postmenopausal women. You may benefit from HRT if you have: Moderate to severe hot flushes and night sweats Are experiencing uncomfortable vaginal symptoms Are at risk of osteoporosis Been through early menopause Oestrogen deficiency 'First and foremost, HRT is for women who are either within the normal menopause age range of 45-55, who have menopausal symptoms, or are under the age of 45 and going through an early menopause,' says Kathy Abernethy, a BMS menopause specialist and author of Menopause: The One Stop Guide. 'Then there are women who are post-menopause who have still got ongoing symptoms. For about 10 to 15 per cent of women, their symptoms will last into their 60s.' There are various different types of HRT. Depending on your age, health and family health history, it's essential to discuss the risks and which format is right for you with your GP or menopause doctor. Hormone replacement therapy is now available more cheaply thanks to a prescription prepayment certificate reducing a woman's HRT costs to less than £20 a year. HRT can be systemic, meaning the drug travels through your bloodstream, and this comes in the form of a pill, gel, spray or skin patch. These typically contain a higher dose of oestrogen than local HRT and can be used to treat any common menopause symptoms. This refers to vaginal oestrogen, which comes in cream, gel, pessary, or ring form, and is used to treat vaginal and urinary symptoms of menopause only. As it is a topical treatment, it minimises the amount of oestrogen absorbed by the body. As women become more prone to urinary tract infections with age, the use of vaginal oestrogen is highly recommended – especially if the risks associated with taking systemic HRT are putting you off, or it is too dangerous for you considering your health issues. 'It can be really beneficial – in fact most of us could be using vaginal oestrogen forever,' says Abernethy. The term 'bioidentical' refers to hormones in the HRT being chemically identical to those your body produces. It is sometimes referred to as 'body-identical', the difference being that body-identical HRT refers to regulated bioidentical hormones that have been the subject of numerous studies and are therefore deemed safer by experts. Some private clinics offer personalised compounded bioidentical HRT to women, after taking samples of their blood and saliva to make a bespoke formulation. Marketed as being 'more natural' than body-identical hormones, this is the type of custom-made hormone treatment taken by Asha at a cost of £400 every eight months. 'These are tailored to me, my health and my lifestyle, and it's the best money I've ever spent. I feel more vibrant, my skin looks better and I'm full of energy,' she says. However, experts consider compounded biodentical HRT a major concern, and the British Menopause Society (BMS) warns against it, stating 'cBHRT products are not recommended by the BMS. They are not evidence-based for effectiveness and safety'. Indeed, neither Dr Elise Dallas, a specialist in menopause care at The London General Practice, or Abernethy recommend cBHRT. 'A private clinic will tell you that it's made to measure just for you and has a little bit of oestrogen, of progesterone, of testosterone,' says Abernethy. 'The problem with that is it's not regulated, and we don't know the risks'. 'The term 'natural' in this context means the same as our own hormones,' says Abernethy. 'And that's exactly what conventional regulated bioidentical HRT does, mimicking what your body would have been producing during your reproductive years. In terms of HRT, we know that this seems to have fewer side effects and possibly fewer risks as well.' Apart from its contraceptive effects, the Mirena also provides the progestogen component of HRT, alongside oestrogen. A Mirena can minimise the unwanted effects of the PMS-type symptoms of the menopause. 'Although it's synthetic progesterone it releases so little and is very suitable for those that have might have bleeding problems at the end of their perimenopause,' says Dallas. According to the NHS, the risks of taking HRT include: Breast cancer Blood clots Stroke HRT can slightly increase the risk of breast cancer. If you've had breast cancer, you'll usually be advised not to take it. The increased risk is low: there are about five extra cases of breast cancer in every 1,000 women who take combined HRT for five years. But cancer risk from taking HRT depends on many different things, like the kind of HRT you take, your age and general health. The risk increases the longer you take it, and the older you are. It falls again after you stop taking it. There is little or no increase in the risk of breast cancer from oestrogen-only HRT, which you can take if you've had a hysterectomy to remove your womb. The safety of HRT can also depend on other things, such as fitness levels, body mass index and how soon during or after menopause you start taking it. Factor in a woman's family and personal medical history and her individual experience of menopausal symptoms, and it is clear that no one size fits all. 'Drinking more than 14 units a week, being sedentary and having a BMI over 30 are bigger risk factors for developing breast cancer than being on HRT,' says Dr Dallas. According to the NHS, HRT tablets can also slightly increase the risk of blood clots and stroke, but the risk is still very low and only applies to tablets, but not gels, sprays or patches. If you're already at risk of blood clots, you'll usually be advised to take HRT gels, sprays or patches. 'The fact is, we don't know if it's safe to take indefinitely, because we don't have the data for taking body identical HRT for 30 years,' says Dallas. 'So, all we can say is that so far, for at least five years there has been no increase in breast cancer cases [among those taking HRT]. However, the evidence is pointing towards it being way more beneficial than not taking it, although we would always counsel women on an individual basis.' This is why it is vital to keep having your health checks if you are on HRT. 'These are essential for looking at that person's individual risk and whether they are generally fit and healthy. If there are no other risks, there is so far no reason why someone cannot continue taking it until the grave,' says Dallas. 'There's no upper age at which you have to stop taking HRT, and there's no maximum duration. However, if you're on a combined HRT the risk of breast cancer, while small, increases with time,' says Abernethy. Menopausal symptoms can return, but furthermore it has an impact on long-term health conditions. 'As soon as you stop taking it, your bones go back to their postmenopausal condition without oestrogen, meaning a high risk of breakage. What's more, HRT is cardioprotective. Oestrogen is an anti-inflammatory, it prevents chronic inflammation and it's been shown that chronic inflammation stimulates all chronic diseases, whether it be heart disease or the beginning of cancers. So, taking that oestrogen away means losing that protection,' says Dallas. HRT has been found to be associated with a small reduction in the risk of bowel cancer. It can also reduce muscle loss that commonly occurs after the menopause and can improve strength. It gives a woman better bone, cardiovascular, brain and skin health compared with a woman that does not take it. 'Oestrogen is in every cell of our body, brains, hearts and bones, and it was found that heart attacks among women [who don't take HRT] increased five times after menopause, because we lack oestrogen. We're much more prone to osteoporosis and have a greater risk of brain disease once we lose our oestrogen protection. In many cases, the benefits of taking HRT outweigh the risks,' says Dallas. Common side effects of HRT include: Breast tenderness Muscle cramps Mood changes Headaches Nausea These symptoms should subside after a few weeks, as your body gets used to it. Vaginal bleeding or spotting is common with HRT, but if you bleed heavily or it continues after six months, discuss this with your GP. You may also experience itchy skin or a mild rash, which may mean you need a different treatment. Your GP can prescribe HRT. If you don't have a sympathetic doctor, it is a good idea to get focused support from an expert, especially if you have challenging symptoms. The BMS website can help you find your nearest menopause specialist. The only HRT you can get as an over-the-counter medication from a chemist is vaginal oestrogen, subject to a consultation with a pharmacist. Known as Gina, this comes in the form of vaginal tablets that are a locally acting oestrogen HRT used to treat the symptoms of vaginal atrophy after the menopause – eg, vaginal soreness and urinary tract infections. It's not uncommon for women to be turned away by their GP when they ask for HRT. If you have a history of blood clots, are prone to migraines, have high blood pressure or have a family history of breast cancer, you should discuss the options with a menopause specialist. You could also be turned away for being too old. If HRT is started within 10 years of the menopause or before the age of 60, it can protect you against osteoporosis and help prevent cardiovascular disease, as well as boosting your energy. If you start later than that, you may not get the same protection and there may be health risks. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

UK CBD drinks maker Goodrays secures new funding
UK CBD drinks maker Goodrays secures new funding

Yahoo

time2 hours ago

  • Yahoo

UK CBD drinks maker Goodrays secures new funding

UK-based CBD drinks maker Goodrays has raised £5m ($6.79m) in a new funding round led by venture capital firm Guinness Ventures. Goodrays said it intends to use the funds to expand its "premium product portfolio", bolster its marketing efforts and secure new listings with retailers, as well as "[accelerate] relationships with existing partners". Alongside the announcement, the business also announced the appointment of Ben Dando, former international chief of canned water brand Liquid Death, as Goodrays' new managing director. According to the UK CBD drinks brand, the investment comes at a 'pivotal moment' for the UK CBD market. Full market authorisation for CBD products is expected in early 2026, marking a shift in CBD's regulatory landscape in the UK. Founder of Goodrays Eoin Keenan said: "This round is a huge milestone on our mission to build the UK's leading premium functional drinks brand. 'We exist to help busy minds find calm and clarity and we're proud to create the most effective and premium functional drinks for people who want to improve their mental wellbeing. 'For too long, mental wellbeing has been ignored by the food and drink industry, dominated by high sugar, hard alcohol and ultra-processed foods. We are changing that,' the founder said. The funding - which combines equity and debt financing – features new and existing investors including celebrity backers Vernon Kay and Tess Daly, among others, according to a statement from the group. Keenan added that the 'support from Guinness Ventures, renowned for their expertise in building iconic brands, combined with Ben's proven track record, positions us perfectly for our next phase of growth and to continue to cement ourselves as a disruptor in the industry.' Without disclosing exact figures, Goodrays also said it has doubled revenue year-on-year for three consecutive years whilst simultaneously doubling profitability. Goodrays sells its range of CBD-infused drinks to major retailers in the UK including Tesco and Sainsbury's. It is also available in Carrefour and Le Clerc retailers in France, among other retailers. Last week, the UK Food Standards Agency (FSA) released new guidance urging CBD businesses to reformulate their food and drink products to meet its provisional acceptable daily intake (ADI) for CBD and a new upper limit for THC. Commenting on the news at the time, Goodrays' Keenan said: 'Having been part of the stakeholder process with the FSA, we're supportive of this change as it's another positive step towards full market authorisation. 'The FSA have set this out as a recommendation rather than a mandated hard change, and the suppliers, the retailers and the FSA all understand that there will be a transition period for all parties to implement this recommendation, which is a sensible approach.' "UK CBD drinks maker Goodrays secures new funding" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store